Search

everythinglearnresearchcommunity

for

Search:↓

Bariatric surgery can cause long-term issues like hair loss, mood swings, and weight regain, needing ongoing care and education.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

More research is needed to understand sex and racial differences in long COVID.

Recent research on androgenetic alopecia focuses on optimizing treatments, with promising new therapies emerging.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

A woman's complete hair loss condition improved after recovering from COVID-19.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

More symptoms during initial COVID infection increase the risk of long-term effects.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.

Genetic differences affect COVID-19 severity and treatment development.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Soybean extract may help hair growth in testosterone-related hair loss.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.